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Breast cancer frequently affects the lungs, and
-40% of patients have pulmonary shadowing or
pleural effusions on chest X-ray at first relapse
(Coombes et al., 1980). About 70% have
histological lung involvement at post mortem
(Thomas et al., 1979). Although the radiological
appearances may be diagnostic or highly suggestive,
this is not always the case, and the clinical and
radiological features may simulate other conditions
such as infection, radiation lung damage or primary
bronchogenic carcinoma. With the advent of
effective palliative endocrine or chemotherapy, early
and definite diagnosis of pulmonary disease has
become more important. For this reason we have
investigated the value of fibreoptic bronchoscopy in
aiding the differential diagnosis of respiratory
symptoms ot an abnormal chest X-ray in patients
with breast cancer.
Twenty-six female patients with histologically-
proven breast cancer presented to a Breast Unit
over a 2-year period with either new respiratory
symptoms (25) or an abnormal routine chest X-ray
(1). Clinically they presented a diagnostic problem.
All the symptomatic patients had cough and/or
dyspnoea as the major complaint, but three had
haemoptysis, two bronchospasm and one hoarseness
of voice. The chest X-ray showed recent change in
19 patients. Only 3 of these showed discreet
pulmonary nodules suggestive of metastasis. The
remainder had non-specific shadowing. Four had
normal chest X-rays, and three had static
abnormalities, such as eg: old tuberculosis, or
radiation fibrosis etc. (Table I). Their ages ranged
from 38-82 years (mean 63 years). The interval
between initial diagnosis of breast cancer and the
onset of respiratory symptoms ranged from 1
month to 15 years (mean 5 years). Fourteen had
Table I Chest X-ray appearance
No. of
Chest X-ray appearance patients*
1. No change (7)
a. Normal 4
b. Static abnormality 3
2. Non specific recent change (16)
a. Pulmonary infiltrate 12
b. Hilar or paratracheal enlargement 4
c. Linear shadows 3
d. Segmental atelectasis 3
e. Pleural effusion 3
3. Discreteperipheral nodules (3)
*Totals in parenthesis.
extrathoracic metastases at the time of
bronchoscopy (11 bone, 4 liver, 6 soft tissue, 1
brain). Three had had preceding malignant pleural
effusions. The remaining 9 patients had no evidence
of metastases.
Patients were admitted as day cases for routine
transnasal fibreoptic bronchoscopy under sedation
and topical anaesthesia. Most patients went home
the same day unless transbronchial lung biopsies
were taken, in which case they were kept under
observation for 24 hours as there is a small risk of
pneumothorax or pulmonary haemorrhage (Zavala,
1975). Four to 8 random bronchial biopsies were
taken throughout the bronchial tree, and in
addition, any abnormal looking bronchial mucosa
was biopsied. If there was an area of interstitial
shadowing on chest X-ray, 2-6 transbronchial lung
biopsies were taken from this area. No attempt was
made to biopsy peripheral pulmonary nodules.
Aspirated bronchial secretions were collected and
submitted for cytology. Histological preparation of
the biopsy specimens was done in the usual way.
Each biopsy was sectioned to 6 levels and stained
with H and E. All the patients tolerated
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Table II Summary of fibreoptic bronchoscopic findings
Extra- On
thoracic systemic Abnormal Positive Positive Positive
Chest Patients metastases therapy mucosa histology cytology TBLB*
X-ray (26) (14) (11) (16) (9) (1) (1)
No
change 7 3 3 1 1 0 0
Non-
specific
change 16 9 7 14 8 1 1
Nodules 3 2 1 1 0 0 0
*Transbronchial lung biopsy.
bronchoscopy extremely well, despite some of them
being severely breathless, even at rest. Nine had
transbronchial lung biopsies and none suffered any
complication.
Sixteen patients (62%) had abnormal looking
bronchial mucosa (Table II). The most common
appearance was a boggy indurated mucosa with no
inflammatory changes and no excess of surface
mucus (11 patients), distinguishing it from
bronchitis. This was usually localised but
occasionally appeared to be diffuse. Other unusual
appearances were whitish nodules or infiltrates (3
patients) or mucosal erythema (2 patients). One
patient had a mucosal tumour mass, which on
biopsy was a squamous carcinoma.
Nine patients (35%) had metastatic breast cancer
on bronchial biopsy. In 5 of these this was the first
presentation of relapse. The metastatic deposits
usually filled the submucosal lymphatics, leaving
the mucosa intact (Figure 1) except in 2 cases
where extensive infiltration involved the mucosa as
well. Four patients had inadequate bronchial
biopsies as judged by insufficient submucosal tissue
for histological comment. Nine patients had
transbronchial biopsies (in addition to bronchial
biopsies) but only one showed pulmonary
metastasis. This patient also had positive bronchial
histology. Another patient showed interstitial
pulmonary fibrosis on transbronchial biopsy. One
patient with positive histology had an entirely
normal chest x-ray, the others had non-specific
shadowing. None had discrete nodular shadows
normally indicative of pulmonary metastasis.
Concurrent chemotherapy or hormonal therapy
did not appear to influence the yield of positive
bronchial biopsies as three out of nine were
receiving therapy at the time of biopsy.
Only one patient had malignant cells on
cytological examination of material aspirated from
the bronchial tree. This patient also had positive
bronchial histology.
Follow-up of patients is now 1-3 years.
Figure 1 Bronchial biopsy (H&E x 690) showing metastatic carcinoma cells filling a submucosal lymphatic
channel. The surface mucosa although metaplastic is intact.FIBREOPTIC BRONCHOSCOPY AND BREAST CANCER METASTASIS 733
Of those with negative biopsies, 5 have lost their
respiratory systems and remain well; 7 had
progressive metastatic pulmonary deteriation; 4
have died from disseminated (non-pulmonary)
breast cancer and one from carcinoma of the lung.
Six patients with positive bronchial biopsies have
died 1-8 months after bronchoscopy (mean 5
months) and 2 remain alive 20 and 28 months later.
This study indicates that bronchoscopy is a
useful investigation in patients with breast cancer
who have respiratory symptoms, particularly if the
chest x-ray is normal or shows non-specific change.
In this series, about one third of the patients had
positive histology on bronchial biopsy. This was the
first manifestation of relapse in over half of them,
and was a great help in their clinical management.
The procedure was very well tolerated and there
were no complications. Fibreoptic bronchoscopy (as
opposed to rigid bronchoscopy) enabled us to
investigate some patients who were extremely
breathless in whom general anaesthesia would have
been hazardous. It also revealed an unsuspected
diagnosis in two patients viz. squamous carcinoma
of the bronchus, and interstitial pulmonary fibrosis.
Despite this remarkably high yield of
endobronchial metastases, however, we believe that
the yield could have been higher. Amongst the 17
patients with negative histology, 3 died within 3
months of bronchoscopy with disseminated
pulmonary disease at autopsy. Four patients,
including one of those who died, had inadequate
biopsy material for diagnosis (i.e.: insufficient
submucosal tissue) emphasizing the need for deep
bronchial biopsies.
Aspiration cytology and transbronchial lung
biopsy provided a remarkably low yield of positive
results, and did not add to the bronchial biopsy
information. Perhaps it is not surprising that
cytology was unhelpful as endobronchial metastasis
does not appear to involve the surface mucosa in
the early stages. Brush cytology, which abrades
away the mucosa may be able to improve this.
Transbronchial lung biopsy was, however,
disappointing. It was done without the aid of
fluoroscopic guidance and perhaps better results
could be obtained with this technique.
Nodular pulmonary deposits are usually highly
suggestive of metastatic disease, and unless there is
diagnostic doubt, we consider bronchoscopy in this
instance to be unnecessary. In our experience,
nodular metastases are frequently asymptomatic
when first diagnosed. They probably represent
haematogenous metastasis and may be unrelated to
lymphatic endobronchial disease. Bronchial biopsies
in 3 patients with nodular metastasis in our series
were negative.
Breast cancer is one of the most common
extrathoracic malignancies to involve the major
bronchi as an autopsy finding (King & Castleman,
1943; Rosenblatt et al., 1966). Rosenblatt et al.
(1966) found 37% of 56 breast cancer patients who
came to autopsy had endobronchial metastases at a
microscopic level. Macroscopic involvement of the
bronchi at autopsy is very much less frequent. King
and Castleman (1943) found 5 cases of macroscopic
endobronchial breast disease in 20 patients with
endobronchial metastases from various
extrathoracic solid tumours collected over 10 years.
Braman and Whitcomb (1975) found no
macroscopic endobronchial metastases among 23
breast cancer patients who had pulmonary
metastases at autopsy.
The major airways may be involved either by
direct extension from mediastinal lymph nodes or
by endobronchial metastatic infiltration (King &
Castleman, 1943). Rosenblatt et al. (1966) gave a
careful histological description of the stages of
involvement, emphasising that in the earliest stages
the submucosal lymphatics were permeated by
malignant cells resulting in distension of the lymph
channels. Later there was coalescence of the swollen
lymphatics to form solid tumour masses under the
bronchial epithelium. These masses eventually
ulcerated through the epithelial layer to form a
polypoid mass within the bronchial lumen. Thomas
et al. (1979) found the lung parenchyma to be
involved in 67% of lungs from patients dying from
carcinoma of the breast and this was usually
intralymphatic and microscopic. They postulated
that once the mediastinal lymph nodes become
involved as a result of normal lymphatic drainage
from the internal mammary nodes, the pulmonary
and bronchial lymphatics become involved by
retrograde extension. Because of proximity,
therefore, it is not surprising that microscopic
endobronchial lymphatic involvement may
accompany or precede pulmonary lymphangitis
carcinomatosa.
Since the first case report (Gardella, 1954) of
endobronchial metastases from carcinoma of the
breast diagnosed at bronchoscopy, there have been
only 41 reported cases subsequently (Gephart, 1960;
Fitzgerald, 1977; De Beer et al., 1978; Gallivan &
Emery, 1978; Tenholder et al., 1978; Krutchik et
al., 1978; Baumgartner & Mark, 1980; Albertini &
Ekberg, 1980; Daskalakis, 1981; Shepherd, 1982)
and 4 cases of endotracheal metastases
(Baumgartner & Mark, 1980; Garces et al., 1974;
Weber & Grillo, 1978), most within the last 5 years
since the advent of fibreoptic bronchoscopy. All
series (Fitzgerald, 1977; Tenholder et al., 1978;
Krutchik et al., 1978; Baumgartner & Mark, 1980;
Albertini & Ekberg, 1980; Shepherd, 1982) have
been retrospective reviews of bronchoscopic734 A.J.R. MORRIS et al.
records. The indications for bronchoscopy were
usually bronchial obstruction or haemoptysis
simulating primary bronchogenic carcinoma, with
bronchoscopic appearances usually of an exophytic
mass occluding a bronchus. Not surprisingly,
therefore, endobronchial metastasis was thought to
be very rare. Krutchik et al. (1978) found six cases
in 1628 consecutive patients with breast cancer
during a 2-year period (0.4%). Only 2 authors have
described less advanced endobronchial appearances.
Albertini & Ekberg (1980) described the mucosal
appearance as firm and oedematous and recognised
that the metastatic malignant cells were usually
present in the submucosal lymphatics. They also
found a low yield of aspiration cytology and
attributed this to the submucosal location of the
disease. These authors felt that endobronchial
metastasis from carcinoma of the breast was very
much more common than was previously accepted.
Despite the late clinical presentation of most of
these cases reviewed, 4/41 had normal chest X-rays
at the time of bronchoscopy, and interestingly, the
first case reported (Gardella, 1954) had persistent
cough and dyspnoea for 3 years before presenting
with bronchial occlusion and haemoptysis.
We conclude, in agreement with Albertini &
Ekberg (1980) that endobronchial metastasis from
carcinoma of the breast is not uncommon, and that
any patient with persistent cough or breathlessness
should have fibreoptic bronchoscopy, particularly if
the chest X-ray is normal or shows non-specific
changes.
We gratefully acknowledge the help and co-operation of
the staff of the Norman Tanner Endoscopy Unit, St.
James' Hospital, and Miss Heather Whippy for typing the
manuscript.
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